These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

316 related articles for article (PubMed ID: 33003610)

  • 1. Cyclic Oligosaccharides as Active Drugs, an Updated Review.
    Matencio A; Caldera F; Cecone C; López-Nicolás JM; Trotta F
    Pharmaceuticals (Basel); 2020 Sep; 13(10):. PubMed ID: 33003610
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A cyclodextrin-based macrocyclic oligosaccharide cavitand with a dual functionality limits the collagen fibrillogenesis: A possible carbohydrate-based therapeutic molecule for fibrotic diseases.
    Veettil SP; Gopinath A; Madhan B; Shanmugam G
    Int J Biol Macromol; 2022 May; 207():222-231. PubMed ID: 35259432
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of a non-cyclodextrin cyclic carbohydrate on mouse melanoma cells: Characterization of a new type of hypopigmenting sugar.
    Nakamura S; Kunikata T; Matsumoto Y; Hanaya T; Harashima A; Nishimoto T; Ushio S
    PLoS One; 2017; 12(10):e0186640. PubMed ID: 29045474
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of Cyclodextrins in Nanoparticle-Based Drug Delivery Systems.
    Shelley H; Babu RJ
    J Pharm Sci; 2018 Jul; 107(7):1741-1753. PubMed ID: 29625157
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cyclodextrin-Based Polymeric Drug Delivery Systems for Cancer Therapy.
    Li X; Liu J; Qiu N
    Polymers (Basel); 2023 Mar; 15(6):. PubMed ID: 36987181
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Self-assembled cyclodextrin aggregates and nanoparticles.
    Messner M; Kurkov SV; Jansook P; Loftsson T
    Int J Pharm; 2010 Mar; 387(1-2):199-208. PubMed ID: 19963052
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cyclic Nigerosyl-Nigerose as Oxygen Nanocarrier to Protect Cellular Models from Hypoxia/Reoxygenation Injury: Implications from an In Vitro Model.
    Penna C; Femminò S; Caldera F; Rubin Pedrazzo A; Cecone C; Alfì E; Comità S; Higashiyama T; Trotta F; Pagliaro P; Cavalli R
    Int J Mol Sci; 2021 Apr; 22(8):. PubMed ID: 33921614
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cyclic nigerosyl-1,6-nigerose-based nanosponges: An innovative pH and time-controlled nanocarrier for improving cancer treatment.
    Caldera F; Argenziano M; Trotta F; Dianzani C; Gigliotti L; Tannous M; Pastero L; Aquilano D; Nishimoto T; Higashiyama T; Cavalli R
    Carbohydr Polym; 2018 Aug; 194():111-121. PubMed ID: 29801818
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Drug Carrier Systems Based on Cyclodextrin Supramolecular Assemblies and Polymers: Present and Perspectives.
    Gonzalez-Gaitano G; Isasi JR; Velaz I; Zornoza A
    Curr Pharm Des; 2017; 23(3):411-432. PubMed ID: 27855609
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cyclodextrin-membrane interaction in drug delivery and membrane structure maintenance.
    Hammoud Z; Khreich N; Auezova L; Fourmentin S; Elaissari A; Greige-Gerges H
    Int J Pharm; 2019 Jun; 564():59-76. PubMed ID: 30959238
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cyclodextrin Monomers and Polymers for Drug Activity Enhancement.
    Matencio A; Hoti G; Monfared YK; Rezayat A; Pedrazzo AR; Caldera F; Trotta F
    Polymers (Basel); 2021 May; 13(11):. PubMed ID: 34064190
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cyclodextrin-based delivery systems for chemotherapeutic anticancer drugs: A review.
    Tian B; Hua S; Liu J
    Carbohydr Polym; 2020 Mar; 232():115805. PubMed ID: 31952603
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Versatile Nasal Application of Cyclodextrins: Excipients and/or Actives?
    Rassu G; Sorrenti M; Catenacci L; Pavan B; Ferraro L; Gavini E; Bonferoni MC; Giunchedi P; Dalpiaz A
    Pharmaceutics; 2021 Jul; 13(8):. PubMed ID: 34452141
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cyclodextrins in non-viral gene delivery.
    Lai WF
    Biomaterials; 2014 Jan; 35(1):401-11. PubMed ID: 24103652
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Polycyclodextrins: Synthesis, functionalization, and applications.
    Seidi F; Jin Y; Xiao H
    Carbohydr Polym; 2020 Aug; 242():116277. PubMed ID: 32564845
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cyclodextrin complexes for treatment improvement in infectious diseases.
    Imperiale JC; Sosnik AD
    Nanomedicine (Lond); 2015 May; 10(10):1621-41. PubMed ID: 26008196
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cyclodextrins in delivery systems: Applications.
    Tiwari G; Tiwari R; Rai AK
    J Pharm Bioallied Sci; 2010 Apr; 2(2):72-9. PubMed ID: 21814436
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cyclodextrins as Drug Carriers in Pharmaceutical Technology: The State of the Art.
    Conceicao J; Adeoye O; Cabral-Marques HM; Lobo JMS
    Curr Pharm Des; 2018; 24(13):1405-1433. PubMed ID: 29256342
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anomalous Properties of Cyclodextrins and Their Complexes in Aqueous Solutions.
    Loftsson T; Sigurdsson HH; Jansook P
    Materials (Basel); 2023 Mar; 16(6):. PubMed ID: 36984102
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cyclodextrin Inclusion of Medicinal Compounds for Enhancement of their Physicochemical and Biopharmaceutical Properties.
    Caira MR
    Curr Top Med Chem; 2019; 19(25):2357-2370. PubMed ID: 31648636
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.